ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016 ACR/ARHP Annual Meeting
    • 2015 ACR/ARHP Annual Meeting
    • 2014 ACR/ARHP Annual Meeting
    • 2013 ACR/ARHP Annual Meeting
    • 2012 ACR/ARHP Annual Meeting
    • 2011 ACR/ARHP Annual Meeting
    • 2010 ACR/ARHP Annual Meeting
    • 2009 ACR/ARHP Annual Meeting
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2016 ACR/ARHP Annual Meeting

November 11-16, 2016 in Washington, DC

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d [e] f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: 1555
    E-Comorbidity: Evaluation of the Validity of Electronic Comorbidity Assessment in Identifying Comorbid Conditions Among Patients with Rheumatoid and Psoriatic Arthritis
  • Abstract Number: 2321
    Early Damage and Mortality in a Cohort of Patients with Myositis Followed up to 20 Years
  • Abstract Number: 2472
    Early DAS28 Drop Is a Predictor for Clinical Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis: An Observational Study of a Real Life Inception Cohort
  • Abstract Number: 489
    Early Detection of Inflammatory Arthritis: The Role of Musculoskeletal Symptoms, Infections and Rheumatoid Arthritis-Related Comorbidities in Primary Care
  • Abstract Number: 1623
    Early Effects of Tofacitinib on Bone Homeostasis in Patients with Rheumatoid Arthritis
  • Abstract Number: 1032
    Early In Vivo Induction of Mouse Interferon-alpha1 Overexpression Triggers an Expansion of Highly Suppressive Regulatory T Lymphocytes Protecting Against Experimental Arthritis
  • Abstract Number: 115
    Early Inflammatory Arthritis Presentation, Management and Outcomes in Canadian Aboriginal Patients
  • Abstract Number: 1457
    Early Onset Morbidity and Mortality in Female Tumor Necrosis Factor Transgenic Mice with Inflammatory-Erosive Arthritis and Interstitial Lung Disease
  • Abstract Number: 1703
    Early Onset of Efficacy with Apremilast Monotherapy in Biologic-Naive Patients with Active Psoriatic Arthritis: A Phase IIIb, Randomized, Controlled Trial
  • Abstract Number: 2045
    Early Preeclampsia Risk in Lupus Pregnancy: A Swedish Population-Based Register Investigation
  • Abstract Number: 3104
    Early Proteinuria Response in Real Life Situation Predicts Long-Term Lupus Renal Outcome in Ethnically Diverse Group with Biopsy-Proven Nephritis
  • Abstract Number: 3211
    Early Radiological Progression in Rheumatoid Arthritis Leads to More Long-Term Joint Damage in Daily Clinical Practice; Six Year Radiological Outcomes of a Strict Treat-to-Target Cohort in the Netherlands
  • Abstract Number: 1619
    EARTH EXPLORER 2, a Phase IIb Exploratory Study Evaluating Efficacy and Safety of Mavrilimumab, a Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor-Alpha Monoclonal Antibody, and the Tumor Necrosis Factor Antagonist Golimumab in Rheumatoid Arthritis
  • Abstract Number: 325
    Ebselen Is a Potential Anti-Osteoporosis Agent By Suppressing RANK Ligand-Induced Osteoclast Differentiation in Vitro and Lipopolysaccharide-Induced Inflammatory Bone Destruction In Vivo
  • Abstract Number: 2630
    EBV Load Quantification in Peripheral Blood Mononuclear Cells of Patients with Rheumatoid Arthritis Treated By Abatacept and Tocilizumab
  • Abstract Number: 2617
    Economic Burden of Non-Responders to Biologic DMARD Treatments in Rheumatoid Arthritis
  • Abstract Number: 2229
    Economic Burden of Rheumatoid Arthritis Is Higher for ACPA-Positive Patients
  • Abstract Number: 3168
    Economic Evaluation of Damage Accrual in an International SLE Inception Cohort
  • Abstract Number: 2234
    Economic Impact of Above-Label Dosing with Biologics in Patients with Moderate-to-Severe Psoriatic Arthritis
  • Abstract Number: 609
    Economic Impact of Adalimumab Treatment in Japanese Patients with Rheumatoid Arthritis from the Anouveau Study (Clinicaltrial.gov: NCT01346488)
  • Abstract Number: 2058
    Ectonucleotidase-Mediated Protection of Lupus Mice from Exaggerated Immune Responses and Arterial Vasculopathy
  • Abstract Number: 421
    Educating Patients on the  Cardiovascular Risks of Rheumatoid Arthritis: Usual Care Versus a Structured Approach
  • Abstract Number: 323
    Effect of 10 Years of Denosumab Treatment on Bone Histology and Histomorphometry in the Freedom Extension Study
  • Abstract Number: 2486
    Effect of a Dynamic Exercise Program in Combination with a Mediterranean Diet in Strength, Joint Mobility and Disease Activity in Women with Rheumatoid Arthritis
  • Abstract Number: 2024
    Effect of a Revised Counselor Training on Skills Development and Knowledge of Volunteers with Systemic Lupus Erythematosus
  • Abstract Number: 268
    Effect of Abatacept Treatment on T Cells in Muscle Tissue and Peripheral Blood in Polymyositis and Dermatomyositis Patients
  • Abstract Number: 1273
    Effect of Anti-Cyclic Citrullinated Protein Antibodies and Rheumatoid Factor on Bone Erosions in Early Rheumatoid Arthritis Patients Using HR-pQCT: A Cross-Sectional Study
  • Abstract Number: 2174
    Effect of Anti-Rheumatic Treatment on Selenium Levels in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
  • Abstract Number: 1640
    Effect of BMI on Baricitinib Efficacy: Pooled Analysis from Two Phase 3 Rheumatoid Arthritis Clinical Trials
  • Abstract Number: 394
    Effect of BMI on Symptoms and Outcomes in Juvenile Idiopathic Arthritis Patients
  • Abstract Number: 2379
    Effect of Canakinumab Treatment on Health-Related Quality of Life in Patients with Periodic Fever Syndromes
  • Abstract Number: 372
    Effect of Chronicity on Pain Behaviors in Collagenase Induced Non-Inflammatory Monoarthritis in Mice
  • Abstract Number: 2795
    Effect of Complete or Partial Proteinuria Recovery Compared to No Recovery at 2 Years after the Diagnosis of Lupus Nephritis on Long Term Outcomes
  • Abstract Number: 1687
    Effect of Concomitant Conventional Disease-Modifying Antirheumatic Drugs (DMARDs) on the Efficacy and Safety of Ixekizumab in Biologic DMARD-Naive Patients with Active Psoriatic Arthritis
  • Abstract Number: 2L
    Effect of Denosumab Compared with Risedronate in Glucocorticoid-Treated Individuals: Results from the 12-Month Primary Analysis of a Randomized, Double-Blind, Active-Controlled Study
  • Abstract Number: 2633
    Effect of Different Biologic Agents on Lipid Profile in Rheumatoid Arthritis
  • Abstract Number: 1764
    Effect of Disease Remission on Organ Damage and Quality of Life in Chinese Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1742
    Effect of DMARD Therapies on NSAID Intake, Quality of Life, and Physical Functioning in Patients with Ankylosing Spondylitis
  • Abstract Number: 2371
    Effect of Etanercept on Several Soluble Biomarkers in a Randomized Controlled Trial of Patients with Erosive Hand Osteoarthritis
  • Abstract Number: 2606
    Effect of Glucocorticoids on Clinical and Radiographic Efficacy Outcomes in Methotrexate-Naive Patients with RA Receiving Tofacitinib or Methotrexate Monotherapy: Analysis of Data from a Phase 3 Trial
  • Abstract Number: 772
    Effect of HMG-CoA Reductase Inhibitor Drugs (Statins) on Systemic Lupus Erythematosus Disease Activity: A Systematic Review and Meta-Analysis
  • Abstract Number: 2549
    Effect of Interleukin-6 Receptor Blockade on Proprotein Convertase Subtilisin/Kexin Type 9 Serum Levels in Rheumatoid Arthritis Patients
  • Abstract Number: 1382
    Effect of Lupus Anticoagulant on Rotational Thromboelastometry in Juvenile Systemic Lupus Erythematosus: Preliminary Data on a Single Center Cohort
  • Abstract Number: 2535
    Effect of Methotrexate in the Presence of Drug and the Appearance of Antibodies Against Tumour Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis
  • Abstract Number: 2372
    Effect of Oxytocin on Osteoarthritis
  • Abstract Number: 1958
    Effect of Poverty Status in 2009, % of Years in Poverty Between 2003 and 2009, and Exiting Poverty Permanently By 2009 on SLE Damage in 2015
  • Abstract Number: 2439
    Effect of Pregnancy Counseling on the Outcome of Pregnancies in Women with Systemic Lupus Erythematosus: A Prospective Observational Study
  • Abstract Number: 2044
    Effect of Pregnancy on Disease Flares in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1057
    Effect of Quantitative Information Concerning Medication Side-Effects on Risk Perception
  • Abstract Number: 3070
    Effect of Sarcopenia, Subcutaneous Adipose Tissue and Abdominal Visceral Fat on Mortality Risk of Community-Dwelling Older Adults: A Population-Based Prospective Cohort Study
  • Abstract Number: 3091
    Effect of Sarilumab on Circulating Biomarkers of Bone and Joint Destruction in Patients with Rheumatoid Arthritis with Inadequate Response to Methotrexate
  • Abstract Number: 2615
    Effect of Sarilumab on Circulating Biomarkers of Bone and Joint Destruction in Patients with Rheumatoid Arthritis with Previous Inadequate Response to Tumor Necrosis Factor Inhibitors
  • Abstract Number: 1434
    Effect of Systemic and Local Inflammation on the Insulin Resistance and Glucose/Lipid Metabolism in Rheumatoid Arthritis: Humans and CIA Mouse Model
  • Abstract Number: 2054
    Effect of Temporary Methotrexate Discontinuation on Efficacy of Seasonal Influenza Vaccination in Patients with Rheumatoid Arthritis: A Randomized Clinical Trial
  • Abstract Number: 2662
    Effect of Tobacco Smoking on the Clinical, Histopathological, and Serological Manifestations of SjöGren’s Syndrome
  • Abstract Number: 621
    Effectiveness and Safety of CT- P13 (Biosimilar Reference Infliximab) in a Real-Life Setting in 151 Patients with Rheumatoid Arthritis and Ankylosing Spondylitis: A Mid-Term Interim Analysis
  • Abstract Number: 981
    Effectiveness of a Six-Week Hand Osteoarthritis Program in a Primary Care Setting
  • Abstract Number: 985
    Effectiveness of a Web-Based Personalized Rheumatoid Arthritis Risk Tool with or without a Health Educator for Knowledge of RA Risk Factors
  • Abstract Number: 1337
    Effectiveness of Certolizumab Pegol in Patients with Uveitis Refractory to Other Tumor Necrosis Factor Inhibitors. Report of 22 Cases
  • Abstract Number: 3206
    Effectiveness of Childhood Vaccinations in CAPS Patients Treated with Canakinumab: Results from an Open-Label Phase III Extension Study
  • Abstract Number: 954
    Effectiveness of Different Dosages of Retreatment of Rituximab in Combination with Leflunomide: Results from a Multicenter Randomized Placebo Controlled Investigator Initiated Clinical Trial in Active Rheumatoid Arthritis (Amara-Study
  • Abstract Number: 2324
    Effects of 12 Weeks Low-Intensity Blood-Flow Restricted Resistance Training on Knee Extensor Strength in Patients with Sporadic Inclusion Body Myositis
  • Abstract Number: 378
    Effects of a Natural Product Containing Specialized Pro-Resolving Mediators in Subjects with OA, RA, or Other Chronic Inflammatory Conditions in a Multi-Clinic Case Series
  • Abstract Number: 2084
    Effects of a Web-Based Patient Decision Aid on Biologics for Rheumatoid Arthritis: A Proof-of-Concept Study
  • Abstract Number: 9
    Effects of Alcohol Consumption on the Severity of Inflammation in Hand and Foot Joints Detected with MR Imaging
  • Abstract Number: 1158
    Effects of an Educational Program Using Treat to Target Strategy in Korean Patients with  Rheumatoid Arthritis
  • Abstract Number: 1748
    Effects of Anti-High Mobility Group Box 1 Antibody for MRL/Lpr lupus-Prone Mice
  • Abstract Number: 2632
    Effects of Baseline Patient Characteristics on Baricitinib Efficacy in Patients with Rheumatoid Arthritis
  • Abstract Number: 2444
    Effects of Disease Activity and Drug Exposure on Pregnancy Outcomes with Inflammatory Arthritis
  • Abstract Number: 97
    Effects of DMARD Tapering on Treatment Costs and Work Productivity in Rheumatoid Arthritis Patients- an Analysis from the Prospective Randomized Controlled Retro- Study
  • Abstract Number: 727
    Effects of Nsaids on Disease Activity in Ankylosing Spondylitis
  • Abstract Number: 349
    Effects of Osteoporosis Treatments for Bone Loss and Pain-Related Behavior in the Hind Limb-Unloaded Mouse Model of Disuse Osteoporosis
  • Abstract Number: 39
    Effects of Pregabalin (Lyrica®) on Cerebrospinal Fluid Substance P in Human Subjects with Fibromyalgia Syndrome
  • Abstract Number: 2236
    Effects of Repository Corticotropin Injection on Medication Use in Patients with Rheumatologic Conditions: A Claims Data Study
  • Abstract Number: 760
    Effects of Type I Interferon Inhibition on Blood Leukocyte Subsets in Patients Treated in a Phase IIb Clinical Study of Anifrolumab in SLE
  • Abstract Number: 622
    Efficacy after Transition to SB5 from Reference Adalimumab (Humira®) Vs. Continuation of SB5 or Reference Adalimumab By Antibodies Developed after Transition from a SB5 Phase III Study
  • Abstract Number: 1690
    Efficacy and Safety of Apremilast and Switch from Etanercept in Patients with Moderate to Severe Psoriasis: 52-Week Results
  • Abstract Number: 12L
    Efficacy and Safety of Atacicept in Patients with Systemic Lupus Erythematosus: Results of a 24-Week Randomized, Placebo-Controlled, Phase IIb Study
  • Abstract Number: 1586
    Efficacy and Safety of Baricitinib in Patients with Rheumatoid Arthritis and an Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs: A United States Subpopulation Analysis from Two Phase 3 Trials
  • Abstract Number: 692
    Efficacy and Safety of Biological Therapy and Target Synthetic Dmards: A Systematic Literature Review Informing the 2016 Update of the ASAS/EULAR Recommendations for the Management of Axial Spondyloarthritis
  • Abstract Number: 1329
    Efficacy and Safety of Biologics in Relapsing Polychondritis: A National Multicenter Study in France
  • Abstract Number: 2380
    Efficacy and Safety of Canakinumab in Patients Aged One to Six Years with Cryopyrin-Associated Periodic Syndromes: Results of an Open-Label, Phase III Extension Study
  • Abstract Number: 9L
    Efficacy and Safety of Canakinumab in Patients with Colchicine-Resistant Familial Mediterranean Fever, Hyper-Immunoglobulin D Syndrome/Mevalonate Kinase Deficiency and TNF Receptor-Associated Periodic Syndrome: 40 Week Results from the Pivotal Phase 3 Umbrella Cluster Trial
  • Abstract Number: 3205
    Efficacy and Safety of Canakinumab in Patients with Periodic Fever Syndromes (Colchicine-Resistant FMF, HIDS/MKD AND TRAPS): Results from a Phase 3, Pivotal, Umbrella Trial
  • Abstract Number: 2374
    Efficacy and Safety of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis: Results from an Open-Label Long-Term Follow-up Study
  • Abstract Number: 2555
    Efficacy and Safety of Conventional and Targeted Synthetic Disease-Modifying Antirheumatic Drugs As Well As Glucocorticoids: A Systematic Literature Review Informing the 2016 Update of the Eular Recommendations for the Management of Rheumatoid Arthritis
  • Abstract Number: 1635
    Efficacy and Safety of CT-P10, Rituximab Biosimilar Candidate, and Innovator Rituximab in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks
  • Abstract Number: 295
    Efficacy and Safety of Fasinumab for Osteoarthritic Pain in Patients with Moderate to Severe Osteoarthritis of the Knees or Hips
  • Abstract Number: 943
    Efficacy and Safety of IL-1 Inhibitors in Amyloidosis Associated with Familial Mediterranean Fever Who Underwent Kidney Transplantation
  • Abstract Number: 625
    Efficacy and Safety of Intravenous Golimumab Plus Methotrexate in Patients 65 Years and Younger and Those Greater Than 65 Years of Age-a Post-Hoc Analysis
  • Abstract Number: 959
    Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis: 52 Week Results from a Phase 3 Study
  • Abstract Number: 3222
    Efficacy and Safety of Monotherapy with Sirukumab, an Anti–IL-6 Cytokine Monoclonal Antibody, Compared with Adalimumab Monotherapy in Biologic-Naive Patients with Active Rheumatoid Arthritis: Results of a Global, Randomized, Double-Blind, Parallel-Group, Phase 3 Study
  • Abstract Number: 733
    Efficacy and Safety of Non-Biological Therapy (Non-Biological Drugs and Non-Pharmacological Interventions): A Systematic Literature Review for the 2016 Update of the ASAS/EULAR Recommendations for the Management of Axial Spondyloarthritis
  • Abstract Number: 1632
    Efficacy and Safety of Sarilumab in Subgroups of Patients with Rheumatoid Arthritis from 2 Phase 3 Studies
  • Abstract Number: 3221
    Efficacy and Safety of Sarilumab Versus Adalimumab in a Phase 3, Randomized, Double-Blind, Monotherapy Study in Patients with Active Rheumatoid Arthritis with Intolerance or Inadequate Response to Methotrexate
  • Abstract Number: 3223
    Efficacy and Safety of Sirukumab, an Anti–IL-6 Cytokine Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis Despite Anti-TNF Therapy: Results from a Randomized, Double-Blind, Placebo-Controlled, Global, Phase 3 Study
  • Abstract Number: 602
    Efficacy and Safety of Switching Between Certolizumab Pegol and Adalimumab after Primary Anti-TNF Treatment Failure: 2-Year Results from a Randomized, Investigator-Blind, Superiority Head-to-Head Study
  • Abstract Number: 1591
    Efficacy and Safety of Switching from Adalimumab to Baricitinib: Phase 3 Data in Patients with Rheumatoid Arthritis
  • Abstract Number: 911
    Efficacy and Safety of Tocilizumab in Patients with Giant Cell Arteritis: Primary and Secondary Outcomes from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial
  • Abstract Number: 976
    Efficacy and Safety of Tocilizumab in Patients with Refractory Takayasu Arteritis: Results from a Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial in Japan
  • Abstract Number: 10L
    Efficacy and Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients with Active Psoriatic Arthritis and an Inadequate Response to Tumor Necrosis Factor Inhibitors: OPAL Beyond, a Randomized, Double Blind, Placebo-Controlled, Phase 3 Trial
  • Abstract Number: 2983
    Efficacy and Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, or Adalimumab in Patients with Active Psoriatic Arthritis and an Inadequate Response to Conventional Synthetic Dmards: A Randomized, Placebo‑Controlled, Phase 3 Trial
  • Abstract Number: 1364
    Efficacy and Safety of Tumour Necrosis Factor Antagonists in a Large Cohort of Juvenile Dermatomyositis Patients
  • Abstract Number: 4L
    Efficacy and Safety Results of Guselkumab, an Anti-IL23 Monoclonal Antibody, in Patients with Active Psoriatic Arthritis over 24 Weeks: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study
  • Abstract Number: 3056
    Efficacy of a Work Disability Prevention Program for People with Rheumatic and Musculoskeletal Conditions: A Randomized Controlled Trial
  • Abstract Number: 2968
    Efficacy of Anti-TNF Alpha in Severe and Refractory Cardiovascular Involvement  of Behcet’s Disease: A Multicenter Observational Study of 18 Patients
  • Abstract Number: 1343
    Efficacy of Biological-Targeted Treatments in MDS-Related Systemic Autoimmune Diseases: Multicenter Retrospective Study of 28 Patients
  • Abstract Number: 53
    Efficacy of Cannabis Flos in Patients with Fibromyalgia: A Monocentric Observational Study
  • Abstract Number: 246
    Efficacy of Colchicine and IL-1 Inhibitors in Amyloidosis Associated with Familial Mediterranean Fever: A Retrospective Analysis
  • Abstract Number: 245
    Efficacy of Cyclophosphamide Therapy in Idiopathic Retroperitoneal Fibrosis in a Retrospective Monocentric Analysis
  • Abstract Number: 712
    Efficacy of Golimumab for Nonradiographic Axial Spondyloarthritis (nr-axSpA): Subgroup Analysis By Baseline MRI and C-Reactive Protein Status
  • Abstract Number: 861
    Efficacy of Methotrexate in Giant Cell Arteritis
  • Abstract Number: 49
    Efficacy of Mirogabalin on Patient-Reported Pain and Sleep Interference in Patients with Diabetic Neuropathic Pain: Secondary Outcomes of a Phase 2 Proof-of-Concept Study
  • Abstract Number: 3248
    Efficacy of Mycophenolate Mofetil and Oral Cyclophosphamide on Skin Thickness: Post-Hoc Analyses from the Scleroderma Lung Study I and II
  • Abstract Number: 848
    Efficacy of Prucalopride in the Treatment of Systemic Sclerosis-Related Intestinal Involvement: Results from an Open Label Cross-over Study
  • Abstract Number: 1896
    Efficacy of Pulmonary Arterial Hypertension-Specific Drugs Combination Therapy in Survival of Patients with Pulmonary Arterial Hypertension Associated with Systemic Sclerosis and Other Connective Tissue Diseases
  • Abstract Number: 2894
    Efficacy of Rituximab in Systemic Sclerosis with Interstitial Lung Disease
  • Abstract Number: 3224
    Efficacy of Sirukumab, an Anti–IL-6 Cytokine Monoclonal Antibody, Based upon Prior Use of Non-Anti-TNF Biologics in Patients with Active Rheumatoid Arthritis Despite Anti-TNF Therapy: Results from a Global Phase 3 Study
  • Abstract Number: 1736
    Efficacy of TNF Inhibitors in Axial Spondyloarthritis According to the Presence of Objective Signs of Inflammation: A Multicentric Retrospective Study
  • Abstract Number: 1609
    Efficacy of Tofacitinib in Patients Who Are Inadequate Responders to Disease-Modifying Antirheumatic Drugs According to Early Versus Late Duration of Rheumatoid Arthritis: Post-Hoc Analysis of Data from Phase 3 Trials
  • Abstract Number: 1117
    EGCG Down-Regulates TNF-α-Induced Mcl-1 Expression By Modulating Mule/Huwe1, β-TrCP, and USP9X Ubiquitin/De-Ubiquitin Ligases in Rheumatoid Arthritis Synovial Fibroblasts
  • Abstract Number: 2672
    Elderly Patients Risk a False Positive Diagnosis of Primary Sjogren’s Syndrome If a Positive Labial Gland Biopsy Is Solely Based on Focus Score
  • Abstract Number: 1483
    Elevated Anti-Cyclic Citrullinated Peptide Antibody Titer Is Associated with Increased Cardiovascular Risk
  • Abstract Number: 2725
    Elevated Disease Activity in Disease-Related Spondyloarthritis Despite Use of Tumor Necrosis Factor Inhibitor Therapies
  • Abstract Number: 1904
    Elevated GITRL Is Associated with Multi-Organ Involvement and Increased Disease Activity of Primarty Sjogren’s Syndrome and Promotes Pathogenic Th1/17 Differentiation
  • Abstract Number: 2706
    Elevated Levels of Serum Myeloid Related Protein 8/14 in Ankylosing Spondylitis: Associated with Peripheral Arthritis and Active Disease
  • Abstract Number: 2577
    Elevated Matrix Metalloproteinases Levels in Oral Fluids of Most Rheumatoid Arthritis Patients, Even without Frank Periodontitis
  • Abstract Number: 3017
    Elevated Neutrophil Extracellular Trap Levels Correlate with Anti-CCP3-IgG and Anti-CCP3-IgA Levels in the Sputum of Individuals at-Risk for Future Rheumatoid Arthritis
  • Abstract Number: 1839
    Elevated Plasma Cell-Free Mitochondrial DNA Defines a Subgroup of Lupus Patients with Membranous Lupus Nephritis
  • Abstract Number: 1078
    Elevated Proportion of CD38highIgD+ b Cells in Peripheral Blood Is Related to Disease Activity in Patients with Primary SjöGren’s Syndrome
  • Abstract Number: 1010
    Elucidating the Activation Profile of Systemic Sclerosis Macrophages
  • Abstract Number: 2931
    Endogenous Nur77 Is a Specific Indicator of Antigen Receptor Signaling in Human T and B Cells
  • Abstract Number: 176
    Endoplasmic Reticulum Stress Induces Lupus Kidney Disease By Facilitating Antigen Cross-Presentation Via the Increase of Endosomal Sec61
  • Abstract Number: 3044
    Endothelin 1 Induces a Myofibroblastic Phenotype in Vascular Smooth Muscle Cells. A Mechanism Potentially Contributing to Vascular Remodeling and Intimal Hyperplasia in Giant Cell Arteritis
  • Abstract Number: 1459
    Enhanced Efficacy of Early Vs. Late IL-1β Antagonism in Murine Arthritis Mediated By Deficiency of the IL-1 Receptor Antagonist IL-1ra
  • Abstract Number: 1563
    Enhanced Expression of mRNA for Response Gene to Complement 32 in CD34+ Cells of the Bone Marrow in Rheumatoid Arthritis
  • Abstract Number: 1137
    Enhancing Pediatric Rheumatology Education through Computer-Assisted Fellow-Taught Case Modules
  • Abstract Number: 1305
    Enriching Rheumatoid Arthritis Trial Cohorts with Erosion Progressors By Screening for Active Erosions (Erosions with Osteitis) with MRI
  • Abstract Number: 64
    Enrichment of Immune Pathways in Genes Under Geographically Restricted Adaptation in the Gullah African American Population of South Carolina
  • Abstract Number: 2011
    Enteric-Coated Mycophenolate Sodium Versus Azathioprine for Patients with Moderate/Severe Active Systemic Lupus Erythematosus: Results from a Phase 3, Randomized, Parallel, Multicentre Study
  • Abstract Number: 399
    Enthesitis in Juvenile Idiopathic Arthritis (JIA)
  • Abstract Number: 3038
    Enumeration and Preliminary Characterisation of Peri-Entheseal Bone Type 3 Innate Lymphoid Cells
  • Abstract Number: 1221
    Environmental Scan of Rheumatoid Arthritis Patient Registries Around the World: An Omeract Initiative
  • Abstract Number: 243
    Eosinophilic Angiocentric Fibrosis : A Mimic of Vasculitis in IgG4 Related Disease Spectrum
  • Abstract Number: 2459
    Epidemiologic Profile of Erectile Dysfunction in SLE: A Multi-Center Study in Latin American Patients
  • Abstract Number: 1814
    Epidemiology and Microbiology of Pneumonia in Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 3190
    Epidemiology of Polymyalgia Rheumatica 2000-2014: A Population Based Study
  • Abstract Number: 68
    Epigenetic and Expression Analysis of Ankylosing Spondylitis Association Loci Point to Key Cell Types Driving Disease
  • Abstract Number: 661
    Epitope Specificity and End-Organ Susceptibility Dictates Anti-Ro52 Mediated Salivary Gland Dysfunction
  • Abstract Number: 2665
    Epratuzumab Treatment of Patients with Systemic Lupus Erythematosus and Secondary Sjogren’s Syndrome: An Exploratory Analysis of Phase 3 Studies
  • Abstract Number: 471
    Epstein-Barr Virus-Induced Expression of Receptor Activator Nuclear Factor-κb Ligand on B Cells Is Possibly Responsible for Erosive Arthritis in Epstein-Barr Virus-Infected Humanized Nonobese Diabetic/Shi-Scid/γcnull Mice
  • Abstract Number: 656
    ERdj5 Function Is Involved in Inflammatory Manifestations of Sjögren’s Syndrome in the Salivary Glands
  • Abstract Number: 2458
    Erectile Dysfunction in Men with Rheumatic Diseases: A Systematic Review
  • Abstract Number: 933
    Erosion Patterns in Seropositive and Seronegative Rheumatoid Arthritis: A Joint-By-Joint Approach
  • Abstract Number: 1884
    Esophageal Dilation and Interstitial Lung Disease Incidence and Progression in Systemic Sclerosis
  • Abstract Number: 2016
    Esophageal Disease in Systemic Sclerosis: Does Heritability Play a Role?
  • Abstract Number: 838
    Esophageal Dysmotility and Interstitial Lung Disease in Patients with Scleroderma: A Retrospective Study
  • Abstract Number: 2675
    Essdai, Clinessdai and DAS Scoring at Diagnosis of Primary Sjogren Syndrome: Association with the Development of Hematologic and Solid Neoplasias in 1301 Patients
  • Abstract Number: 1244
    Establishing a Case Report Form (CRF) for Systemic Autoimmune Diseases Studies
  • Abstract Number: 1413
    Establishing Clinical Severity for Patient Reported Outcomes Measurement Information System Measures in Adult Patients with Rheumatic Diseases
  • Abstract Number: 2392
    Establishing Quality of Life Content Domains in Pediatric Localized Scleroderma
  • Abstract Number: 915
    Establishment of a Powerful Method to Identify Autoantigens Expressed on the Cell Surface
  • Abstract Number: 796
    Establishment of an International Autoantibody Standard for Anti-DFS70/LEDGF Antibodies: Proof-of-Concept Study for a Novel Strategy for the Setting up of International Autoantibody Standards
  • Abstract Number: 2252
    Estimated Cost of SLE Hospitalizations
  • Abstract Number: 1431
    Estimates of Global Status By Physicians and Patients Are More Likely to be Discordant in Osteoarthritis Than in Rheumatoid Arthritis
  • Abstract Number: 1039
    Estimation of the Risk of Developing Rheumatoid Arthritis in High-Risk Subjects : Systematic Review and Meta-Analysis
  • Abstract Number: 2579
    Etanercept Treatment Does Not Adversely Affect Traditional Cardiovascular Risk Factors in Patients with Rheumatoid Arthritis
  • Abstract Number: 264
    Ethnicity-Related Differences in the Clinical Presentation of Sarcoidosis in Spain (SARCOGEAS-SEMI Registry)
  • Abstract Number: 2678
    EULAR Primary SjöGren’s Syndrome Disease Activity Index (ESSDAI), Results from the National Registry of the Spanish Society of Rheumatology (SJÖGRENSER)
  • Abstract Number: 776
    Eurolupus and Low Steroid Regimen in Proliferative Lupus Nephritis: Retrospective Evaluation of 38 Patients in the Black Population of Martinique
  • Abstract Number: 411
    Evaluating Levels of Activity and Health-Related Quality of Life in a Cohort of Youth Athletes with Juvenile Idiopathic Arthritis
  • Abstract Number: 2727
    Evaluating Psoriatic Arthritis and Psoriasis Skin Lesions: Ultrasound As a Complementary Measure
  • Abstract Number: 1288
    Evaluating Rheumatoid Arthritis Disease Activity Using Global Assessment of 18f-FDG Uptake in the Joints
  • Abstract Number: 1053
    Evaluating the Charla De Lupus (Lupus Chat)® Program’s Teen, Young Adult and Parent Support Group: Reaching the Hispanic/Latino Community through a Family Model of Support
  • Abstract Number: 2048
    Evaluating Transfer of Certolizumab Pegol into Breast Milk: Results from a Prospective, Postmarketing, Multicenter Pharmacokinetic Study
  • Abstract Number: 1037
    Evaluation of 14-3-3η As a Tool for Diagnosis of Early RA in a European Cohort
  • Abstract Number: 341
    Evaluation of 25-Hydroxyvitamin D Levels in Rheumatologic Diseases
  • Abstract Number: 3113
    Evaluation of a Clinical Transition Pathway for Adolescents with Autoimmune Diseases
  • Abstract Number: 1253
    Evaluation of a Pre-Assessment Tool to Define the Spectrum of Autoimmune Diseases in an Underserved Environment
  • Abstract Number: 1948
    Evaluation of Body Composition Parameters in Granulomatosis with Polyangiitis: Association of Fat Mass Parameters with Disease Activity and Inflammatory Markers
  • Abstract Number: 2323
    Evaluation of Case-Finding Algorithms for Identification of Patients with Dermatomyositis
  • Abstract Number: 1600
    Evaluation of Disease Activity in Patients with Rheumatoid Arthritis Treated with Tofacitinib By RAPID3: An Analysis of Data from 6 Phase 3 Studies
  • Abstract Number: 2382
    Evaluation of Intestinal Inflammation in Children with FMF
  • Abstract Number: 1387
    Evaluation of Mild to Moderate SLE Flare in Patients with Childhood-Onset Disease
  • Abstract Number: 362
    Evaluation of Osteoporosis Risk Factors in Lung Transplant Patients
  • Abstract Number: 2451
    Evaluation of Ovarian Reserve and Function in Adolescent Females with Systemic Lupus Erythematosus
  • Abstract Number: 85
    Evaluation of Patient Satisfaction with the on-Tracc Program; Benefits of a Joint Approach
  • Abstract Number: 1379
    Evaluation of S100 Proteins As Potential Biomarkers of Global and Renal-Specific Disease Activity in Childhood-Onset Systemic Lupus Erythematosus
  • Abstract Number: 1275
    Evaluation of Spine and Tibia Bone Microarchitecture Using Trabecular Bone Score (TBS) and HR-pQCT in Patients with Ankylosing Spondylitis
  • Abstract Number: 1226
    Evaluation of the Association Between C-Reactive Protein and Anti-Citrullinated Protein Antibody in Rheumatoid Arthritis: Analysis of Two Clinical Practice Data Sets
  • Abstract Number: 749
    Evaluation of the Efficacy, Safety, and Tolerability of BIIB023 As an Adjunct to Standard of Care in Subjects with Lupus Nephritis
  • Abstract Number: 478
    Evaluation of the Relationship Between Methotrexate Polyglutamation and Efficacy in the Collagen-Induced Arthritis Mouse Model
  • Abstract Number: 1373
    Evaluation of the Reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) and Cutaneous Assessment Tool Binary Method (CAT-BM) in Juvenile Dermatomyositis Among Pediatric Dermatologists, Rheumatologists, and Neurologists
  • Abstract Number: 2664
    Evaluation of Thyroid Autoimmune Disease in Primary SjöGren’s Syndrome and Its Association with Disease Phenotype
  • Abstract Number: 155
    Evaluation of Ultrasonography As Modality for Identification of Calcium Crystal Deposits in Patients of Primary Osteoarthritis of Knee Joint
  • Abstract Number: 775
    Evaluation of Use of Belimumab in Clinical Practice Settings: Results in Argentina
  • Abstract Number: 1366
    Evidence Based Criteria for Corticosteroid Tapering/Discontinuation. an Analysis of the Paediatric Rheumatology International Trials Organization (PRINTO) Trial in New Onset Juvenile Dermatomyositis
  • Abstract Number: 2184
    Evidence Based Physical Activity Threshold to Predict Improved/High Function in Older Adults with Lower Extremity Conditions: The Osteoarthritis Initiative
  • Abstract Number: 1921
    Evidence for Prevotella Copri As an Immune-Relevant Bacterium in Rheumatoid Arthritis
  • Abstract Number: 373
    Evidence for TMJ Pain As a Component of a Generalized Pain Phenotype
  • Abstract Number: 3030
    Evidence of Inflammasome Activation in the Peripheral Blood and Salivary Gland Tissues of Primary Sjögren’s Syndrome Patients: Correlation with Clinical Indices of Severe Disease and Lymphoma Development
  • Abstract Number: 1516
    Evidence of Labial Salivary Gland Epithelial Cell Activation from Patients with Rheumatoid Arthritis and Sicca Symptomatology
  • Abstract Number: 2274
    Evidence of Phospho-Degron Regulating Expression of Urate Secretory Transporter ABCG2
  • Abstract Number: 2693
    Evolution of Disease Activity over a 5-Year Period in the  395 Patients with Primary SjöGren’s Syndrome of the Assess Prospective Cohort
  • Abstract Number: 2722
    Evolution over Thirty Years of the Profile of Inpatients with Reactive Arthritis in a Tertiary Rheumatology Unit
  • Abstract Number: 535
    Examination of Diurnal and Daily Variation of the Multi-Biomarker Disease Activity (MBDA) Score in RA to Establish the Minimally Important Difference
  • Abstract Number: 208
    Examination of Serum Uric Acid (sUA) Lowering and Safety with Extended Lesinurad + Allopurinol Treatment in Subjects with Gout
  • Abstract Number: 1891
    Excellent Reliability of Semiquantitative Nailfold Capillaroscopy Assessment in a Systemic Sclerosis Cohort – a Pilot Study
  • Abstract Number: 826
    Exercise Echocardiography Predicts Future Development of Pulmonary Hypertension in a High-Risk Cohort of Scleroderma Patients
  • Abstract Number: 1883
    Exercise Habits and Factors Associated with Exercise in Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network (SPIN) Cohort Study
  • Abstract Number: 2860
    Exercise Significantly Improves Cardiorespiratory Fitness and Reduces Disease-Related Fatigue without Adverse Effects on Disease Activity in Systemic Lupus Erythematosus: a Systematic Review with Meta-Analysis
  • Abstract Number: 2277
    Exon Sequencing Reveals a Significant Burden of Non-Synonymous Variants in Both SLC22A11 (OAT4) and SLC22A12 (URAT1) in European Hyperuricemic Individuals
  • Abstract Number: 1092
    Expansion of Age Associated B Cells in Murine Lupus Is Regulated By DEF6 and Its Homologue Swap-70
  • Abstract Number: 1088
    Expansion of Transitional B Cells in SLE Patients Correlates with Increased Toll-like Receptor 7 Expression
  • Abstract Number: 329
    Explore the Possible Mechanisms of 1,25(OH)2D3 on the Formation of Osteoclasts in Rheumatoid Arthritis
  • Abstract Number: 1153
    Exploring Perceptions of a Rheumatoid Arthritis Specific Smoking Cessation Programme
  • Abstract Number: 488
    Exploring the Association Between Air Pollutant Exposure and Seropositivity in Rheumatoid Arthritis
  • Abstract Number: 1477
    Exploring the Inadequate Cardiovascular Disease Prevention in Inflammatory Joint Diseases: Results from a Nationwide Norwegian Project
  • Abstract Number: 1484
    Exploring the Link Between RA Disease Activity, Lipid Levels, and Cardiovascular Disease in an Early Inflammatory Arthritis Cohort
  • Abstract Number: 2005
    Exploring the Window of Opportunity for Drug-Free Clinical Remission in Patients with Active, Very Early Peripheral Spondyloarthritis
  • Abstract Number: 2114
    Exposure to Carbamylated Self- and Non-Self-Proteins Can Lead to a Break-of -Tolerance and the Induction of Autoimmunity
  • Abstract Number: 643
    Exposure-Response Analyses of Efficacy of ABT-122, a Dual-Variable Domain Immunoglobulin (DVD-Ig™) Targeting TNF-α and IL-17A, Compared with Adalimumab in Subjects with Rheumatoid Arthritis and Background MTX
  • Abstract Number: 761
    Exposure-Response Analysis for Selection of Optimal Dosage Regimen of Anifrolumab in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 874
    Expression and Function of IL-12/23 Related Cytokine Subunits (p35, p40 and p19)  in Giant-Cell Arteritis Lesions.  Potential Role of p40 in Promoting Th1 -Mediated Pathways
  • Abstract Number: 2885
    Expression Levels and Function of the Inhibitory Molecule, Immunoglobulin like Transcript 7 (ILT7), Are Decreased on Circulating Plasmacytoid Dendritic Cells in SLE Patients with High ANA Titers
  • Abstract Number: 278
    Expression of Anti-Microbial Peptide LL-37 Correlates to the Activation of Type I Interferon Pathway in Patients with Idiopathic Inflammatory Myopathies
  • Abstract Number: 1744
    Expression of C1q By Podocytes at Late Stages of Proliferative Lupus Glomerulonephritis
  • Abstract Number: 3239
    Expression of IFN-Regulated Genes in Autoantibody Exposed Babies in Utero
  • Abstract Number: 2071
    Expression of Neuraminidase 1 (NEU1) Is Upregulated in the Lungs of Scleroderma Patients with Pulmonary Fibrosis, and Gene Delivery of NEU1 to Mouse Lungs Elicits Accumulation of CD8+ Lymphocytes and Collagen
  • Abstract Number: 660
    Expression of the Chemokine Receptor CXCR5 Is Decreased in the Periphery of Patients with Primary Sjogren’s Syndrome
  • Abstract Number: 657
    Expression of Type-III Interferons (IFNλs) and Their Receptor in Sjögren’s Syndrome
  • Abstract Number: 1473
    Expression of Vitamin D Receptor Associated Genes in the Aorta of Coronary Artery Disease Patients with and without Rheumatoid Arthritis
  • Abstract Number: 2962
    Expression Profile of Chemokines Is Skewed to Th17/Th22 Recruitment in Circulation of Patients with Behcet’s Disease
  • Abstract Number: 1303
    Extended T2-Times in Cardiovascular Magnetic Resonance (CMR) in Patients with Systemic Lupus Erythematosus (SLE) and Persisted Dyspnoea: Is SLE-Associated Myocarditis an Underestimated Problem?
  • Abstract Number: 1218
    Extensive Genetic Overlap of Traits Related to Gout, Hyperuricemia and Its Comorbidities
  • Abstract Number: 2129
    Extracellular Adenosine Deficiency Plays a Role in the Pathogenesis of Osteoarthritis (OA) and Adenosine Replacement Prevents Post-Traumatic Osteoarthritis
  • Abstract Number: 283
    Extracellular Histidyl-tRNA Synthetase in Myositis
  • Abstract Number: 1127
    Extracellular Macrophage Migration Inhibitory Factor Is Essential for Hypoxia-Induced Angiogenesis in a Hypoxia Inducible Factor Independent Manner
  • Abstract Number: 1114
    Extracellular Vesicles in the Circulating of Rheumatoid Arthritis Patients Are Pro-Inflammatory
  • Abstract Number: 820
    EZH2 Modulates Angiogenesis and Fibrosis in Scleroderma
Jump to:  View All • a b c d [e] f g h i j k l m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Annual Meeting in Atlanta, Georgia

© COPYRIGHT 2019 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.